| Balance Sheets | 2025-09-30 | 2025-06-30 | ||
|---|---|---|---|---|
| Cash and cash equivalents | 7,847,911 | 9,014,108 | ||
| Prepaid expenses and other current assets | 1,073,641 | 1,038,794 | ||
| Total current assets | 8,921,552 | 10,052,902 | ||
| Crypto assets, at fair value | 274,695 | - | ||
| Operating lease right-of-use asset, net | 11,464 | 18,081 | ||
| Investment in joint ventures at fair value | 36,819 | 36,819 | ||
| Total non-current assets | 322,978 | 54,900 | ||
| Total assets | 9,244,530 | 10,107,802 | ||
| Accounts payable | 400,067 | 75,510 | ||
| Accrued expenses | 599,018 | 267,794 | ||
| Operating lease liability, current portion | 13,599 | 21,326 | ||
| Total current liabilities | 1,012,684 | 364,630 | ||
| Operating lease liability, less current portion | 0 | 0 | ||
| Total long-term liabilities | 0 | 0 | ||
| Total liabilities | 1,012,684 | 364,630 | ||
| Common stock, 0.0001 par value 50,000,000 shares authorized 15,127,622 and 8,042,747 shares issued and outstanding as of september 30, 2025 and december 31, 2024, respectively | 1,513 | 1,323 | ||
| Additional paid-in capital | 78,410,459 | 75,815,158 | ||
| Accumulated deficit | -70,191,154 | -66,085,353 | ||
| Accumulated other comprehensive income | 11,028 | 12,044 | ||
| Preferred stock, value | 0 | 0 | ||
| Preferred stock, value-Series APreferred Stock | 0 | 0 | ||
| Preferred stock, value-Series BPreferred Stock | 0 | 0 | ||
| Total stockholders equity | 8,231,846 | 9,743,172 | ||
| Total liabilities and stockholders equity | 9,244,530 | 10,107,802 | ||
Hoth Therapeutics, Inc. (HOTH)
Hoth Therapeutics, Inc. (HOTH)